Another major field in PLK1 research is developing PLK1 small‐molecule inhibitors as drug therapies in diseases such as cancer (reviewed in Elizabeth, Gutteridge, Ndiaye, Liu, & Ahmad, 2016; Murugan et al., 2011). This evidence concerns the gene PLK1 and cancer.